Lu Wang

Keverprazan, a novel potassium‐competitive acid blocker: Multiple oral doses safety, tolerability, pharmacokinetics, and pharmacodynamics in healthy subjects

Sufeng Zhou, Lijun Xie, Chen Zhou et al. · Clinical and Translational Science · 2023 · 18 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Keverprazan, a novel potassium-competitive acid blocker: Single ascending dose safety, tolerability, pharmacokinetics, pharmacodynamics and food effect in healthy subjects

Sufeng Zhou, Lijun Xie, Chen Zhou et al. · European Journal of Pharmaceutical Sciences · 2023 · 14 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

Development of an UPLC–MS/MS method for quantification of Avitinib (AC0010) and its five metabolites in human cerebrospinal fluid: Application to a study of the blood-brain barrier penetration rate of non-small cell lung cancer patients

Weicong Wang, Xin Xiao Zheng, Hanping Wang et al. · Journal of Pharmaceutical and Biomedical Analysis · 2017 · 13 citations

Pharmacy, Pharmacokinetics, Pharmacology +15